Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
A mitochondria-targeted tetrapeptide in clinical trials for mitochondrial myopathy, heart failure, and age-related mitochondrial dysfunction, with FDA Fast Track designation.
Lowest Price
$75.00
Highest Price
$1125.00
Average Price
$291.28
Potential Savings
72%
across 7 options
vial · 50mghydroresearchpeptides.com
$3.50/mg
36% more per mg
Prices are estimates and may vary. For research use only. We may earn a commission on purchases through affiliate links. Not medical advice.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Every vendor on this page is verified for endotoxin testing — not just HPLC purity.
Szeto & Birk (2014) demonstrated SS-31 targets cardiolipin to optimize mitochondrial electron transport. The TAZPOWER trial in Barth syndrome showed improvements in cardiac function. Phase 2 trials in primary mitochondrial myopathy (MMPOWER) showed trends toward improvement in 6-minute walk test. Results in heart failure (PROGRESS-HF) showed improved left ventricular volumes. Clinical trial doses range from 4mg to 40mg SubQ daily with generally favorable safety profiles across dose ranges.
This platform provides informational tools only, not medical advice.
Prices verified as of April 2026. Actual prices may vary. For research use only.
Disclosed Labs